Show simple item record

dc.contributor.authorKhalil, Bilal
dc.contributor.authorCabirol-Pol, Marie-Jeanne
dc.contributor.authorMiguel, Laetitia
dc.contributor.authorWhitworth, Alexander J
dc.contributor.authorLecourtois, Magalie
dc.contributor.authorLiévens, Jean-Charles
dc.date.accessioned2019-04-05T23:32:53Z
dc.date.available2019-04-05T23:32:53Z
dc.date.issued2017-06
dc.identifier.issn0197-4580
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/291288
dc.description.abstractTransactive response DNA-binding protein 43 kDa (TDP-43) is considered a major pathological protein in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. The precise mechanisms by which TDP-43 dysregulation leads to toxicity in neurons are not fully understood. Using TDP-43-expressing Drosophila, we examined whether mitochondrial dysfunction is a central determinant in TDP-43 pathogenesis. Expression of human wild-type TDP-43 in Drosophila neurons results in abnormally small mitochondria. The mitochondrial fragmentation is correlated with a specific decrease in the mRNA and protein levels of the Drosophila profusion gene mitofusin/marf. Importantly, overexpression of Marf ameliorates defects in spontaneous walking activity and startle-induced climbing response of TDP-43-expressing flies. Partial inactivation of the mitochondrial profission factor, dynamin-related protein 1, also mitigates TDP-43-induced locomotor deficits. Expression of TDP-43 impairs neuromuscular junction transmission upon repetitive stimulation of the giant fiber circuit that controls flight muscles, which is also ameliorated by Marf overexpression. We show here for the first time that enhancing the profusion gene mitofusin/marf is beneficial in an in vivo model of TDP-43 proteinopathies, serving as a potential therapeutic target.
dc.description.sponsorshipB. K. had a PhD fellowship from the Ministère de la Recherche. J. C. L. and M. L. are supported by a grant from the Association pour la recherche sur la Sclérose Latérale Amyotrophique et autres Maladies du Motoneurone (ARSLA). M. L. is also supported by a grant from the Région Haute-Normandie.
dc.languageeng
dc.publisherElsevier BV
dc.rightsAll rights reserved
dc.subjectALS
dc.subjectDynamin-related protein 1
dc.subjectFTLD
dc.subjectMitochondria
dc.subjectMitochondrial dynamics
dc.subjectAnimals
dc.subjectDNA-Binding Proteins
dc.subjectDisease Models, Animal
dc.subjectDrosophila
dc.subjectDrosophila Proteins
dc.subjectDynamins
dc.subjectGene Expression
dc.subjectLocomotion
dc.subjectMembrane Proteins
dc.subjectMitochondria
dc.subjectMitochondrial Dynamics
dc.subjectMolecular Targeted Therapy
dc.subjectNeuromuscular Junction
dc.subjectNeurons
dc.subjectRNA, Messenger
dc.subjectTDP-43 Proteinopathies
dc.titleEnhancing Mitofusin/Marf ameliorates neuromuscular dysfunction in Drosophila models of TDP-43 proteinopathies.
dc.typeArticle
prism.endingPage83
prism.publicationDate2017
prism.publicationNameNeurobiology of Aging
prism.startingPage71
prism.volume54
dc.identifier.doi10.17863/CAM.38467
dcterms.dateAccepted2017-02-22
rioxxterms.versionofrecord10.1016/j.neurobiolaging.2017.02.016
rioxxterms.versionAM
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2017-06
dc.contributor.orcidWhitworth, Alex [0000-0002-1154-6629]
dc.identifier.eissn1558-1497
rioxxterms.typeJournal Article/Review
pubs.funder-project-idMedical Research Council (MC_UP_1501/1)
pubs.funder-project-idMedical Research Council (MC_UU_00015/6)
cam.issuedOnline2017-02-27
rioxxterms.freetoread.startdate2018-06-30


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record